VentiRx Pharmaceuticals Inc. Report issue

For profit Phase 1 Phase 2
Founded: Seattle WA United States (2006)
Status: Acquired by Celgene (2017) → now Bristol-Myers Squibb (2019)

Organization Overview

First Clinical Trial
2008
NCT00688415
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree